Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

Surgery may be needed for resistant thyrotoxicosis.

The non-cross-linked hyaluronic acid compound effectively and safely improves keratosis pilaris.

An 11-year-old girl's hair regrew after treating her thyroid condition with carbimazole.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

KLHL24-mutant stem cells help understand skin and heart disease.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Thyroid hormones are important for skin health and changes in them can affect conditions like hair loss and eczema.

Cell-based therapy using specific immune cells may help treat alopecia areata by promoting hair regrowth.

Removing the thymoma improved the patient's alopecia areata, suggesting a possible link between the two.

KX-826 is safe and effectively increases hair count in men with hair loss.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Oral betamethasone works faster than oral tofacitinib for hair regrowth in alopecia areata.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.

Older patients without prior JAK inhibitor treatment respond best to tofacitinib for alopecia areata.

Tofacitinib may be an effective and safe treatment for adolescent alopecia areata.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

A single dose of Platelet Rich Plasma effectively reduces symptoms of early knee osteoarthritis.

Blue-light activation of TrkA improves hair-follicle stem cells' ability to become neurons and glial cells.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Proactive physical therapy improved mobility, reduced fatigue, and pain in lupus patients.

A specific thyroid hormone resistance mutation may be linked to different types of hair loss.

The skin produces and responds to thyroid-stimulating hormone, which is controlled by other thyroid-related hormones.

Most patients with Tuberous sclerosis had neurological or skin issues, and over half had psychiatric problems.

Thermobalancing therapy is safe and effective for treating enlarged prostates.

The study found that Keratosis Pilaris Atrophicans is a genetic skin condition that starts in childhood, involves inflammation and scarring, and current treatments are only somewhat effective.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.